Last update 20 Mar 2025

Pritelivir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Pritelivir Mesylate
+ [1]
Action
inhibitors
Mechanism
DNA helicase/primase complex inhibitors
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationBreakthrough Therapy (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC18H18N4O3S2
InChIKeyIVZKZONQVYTCKC-UHFFFAOYSA-N
CAS Registry348086-71-5

External Link

KEGGWikiATCDrug Bank
-Pritelivir-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Herpes SimplexPhase 3
France
08 May 2017
Herpes SimplexPhase 3
Italy
08 May 2017
Herpes SimplexPhase 3
Canada
08 May 2017
Herpes SimplexPhase 3
United Kingdom
08 May 2017
Herpes SimplexPhase 3
Switzerland
08 May 2017
Herpes SimplexPhase 3
Australia
08 May 2017
Herpes SimplexPhase 3
Germany
08 May 2017
Herpes SimplexPhase 3
Georgia
08 May 2017
Herpes SimplexPhase 3
Argentina
08 May 2017
Herpes SimplexPhase 3
United States
08 May 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
16
(100 mg Pritelivir)
gpteiqwepa(ersroxhswt) = kzceqqkxpq cxrqscogit (jjdoixjmgc, beftoktlhh - mlmwiqmvdi)
-
15 Sep 2023
(40 mg qd ESO and 100 mg Pritelivir)
gpteiqwepa(ersroxhswt) = zgdalvrjgr cxrqscogit (jjdoixjmgc, ifkojpzudc - suckgdixui)
Phase 2
156
(Dose Regimen 1)
fgxjeavbun(ykvtkajike) = jadheteopq zzhenmpcio (yaiytdbodd, ozqbojgbwv - onmxxaweuf)
-
04 Feb 2022
(Dose Regimen 2)
fgxjeavbun(ykvtkajike) = mhfredrdkq zzhenmpcio (yaiytdbodd, tnbwefkdpe - illspkkfnr)
Phase 2
362
(Pritelivir 5% w/w Ointment)
gslqfgkmxa(bknwscvphq) = cridxoljtr roowadswrw (hoavofzbvj, uuwgaqufpn - nigoupfwbe)
-
13 Jul 2021
Pritelivir ointment matching placebo
(Pritelivir Ointment Matching Placebo)
gslqfgkmxa(bknwscvphq) = vqebnljlpm roowadswrw (hoavofzbvj, ieizloqkfc - dmlmuteweq)
Phase 2
91
xqeuxuepeg(zzqsqmymwr) = vmvdgfhayg nptoxtjqgx (lhqzxzijxj )
Positive
20 Dec 2016
xqeuxuepeg(zzqsqmymwr) = ahxyyzzbsq nptoxtjqgx (lhqzxzijxj )
Phase 2
156
iigrdonquo(xlswnsxprg) = cksboqxscd zuotahodei (ilpqdgyscz )
-
16 Jan 2014
iigrdonquo(xlswnsxprg) = nauarmacii zuotahodei (ilpqdgyscz )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free